Decreased cell viability was also discovered in breast cancer MCF-7 cells transfected with FAS siRNA (Pham et al., 2021), and it also sensitized doxorubicin, accompanied by decreased PARP1 (Wu et al., 2014). This evidence concerns the gene FAS and breast carcinoma.